Roles
Associate Professor of Clinical Medicine
-
Biography
Dr. Jose F. Camargo is a Transplant Infectious Diseases specialist with over 10 years of experience. He completed a post-doctoral research fellowship in immunogenetics at the University of Texas Health Science Center at San Antonio; and underwent Internal Medicine training at Jacobi Medical Center/Albert Einstein College of Medicine in New York; followed by an Infectious Diseases fellowship at Westchester Medical Center/New York Medical College, and a Transplant Infectious Diseases fellowship at the University of Toronto. Currently, he is an Associate Professor of Medicine, Immunocompromised Host Section, Division of Infectious Diseases at University of Miami, Miller School of Medicine. His main focus is prevention and treatment of various infections in solid organ transplant recipients, patients undergoing chemotherapy for hematological malignancy or those undergoing transplantation and cellular therapy. He has more than 100 scientific publications including prestigious journals such as Nature Medicine, Nature Immunology, and Blood, and has served as ad-hoc reviewer for PLOS One, American Journal of Transplantation, Clinical Transplantation, Lancet Infectious Diseases, Clinical Infectious Diseases, among others; he is also a member of the editorial board of Transplant Infectious Diseases. His research interests include CMV and Aspergillus infections, vaccine immunogenicity, and cell-mediated immunity. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
No result found
-
Teaching Interests
Infections in immunocompromised hosts, in particular chemotherapy and transplant recipients -
Research Interests
- Cell immunity monitoring to predict risk of cytomegalovirus infection in hematopoietic stem cell transplant recipients.
- Risk factors and outcomes of Aspergillus infections in chemotherapy and transplant patients in the current era.
- Vaccine immunogenicity in HCT recipients.
- Infectious complications in CAR-T cell therapy.
- Infectious complications as immune related adverse events in patients receiving immune checkpoint inhibitors. -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
-
Copyrights & Patents
-
Professional Activities
No result found
